1. Home
  2. COUR vs VERA Comparison

COUR vs VERA Comparison

Compare COUR & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COUR
  • VERA
  • Stock Information
  • Founded
  • COUR 2012
  • VERA 2016
  • Country
  • COUR United States
  • VERA United States
  • Employees
  • COUR N/A
  • VERA N/A
  • Industry
  • COUR Computer Software: Prepackaged Software
  • VERA Biotechnology: Pharmaceutical Preparations
  • Sector
  • COUR Technology
  • VERA Health Care
  • Exchange
  • COUR Nasdaq
  • VERA Nasdaq
  • Market Cap
  • COUR 1.8B
  • VERA 1.7B
  • IPO Year
  • COUR 2021
  • VERA 2021
  • Fundamental
  • Price
  • COUR $10.65
  • VERA $30.08
  • Analyst Decision
  • COUR Buy
  • VERA Buy
  • Analyst Count
  • COUR 14
  • VERA 9
  • Target Price
  • COUR $11.59
  • VERA $62.25
  • AVG Volume (30 Days)
  • COUR 2.6M
  • VERA 1.3M
  • Earning Date
  • COUR 10-23-2025
  • VERA 11-06-2025
  • Dividend Yield
  • COUR N/A
  • VERA N/A
  • EPS Growth
  • COUR N/A
  • VERA N/A
  • EPS
  • COUR N/A
  • VERA N/A
  • Revenue
  • COUR $721,674,000.00
  • VERA N/A
  • Revenue This Year
  • COUR $9.31
  • VERA N/A
  • Revenue Next Year
  • COUR $5.64
  • VERA N/A
  • P/E Ratio
  • COUR N/A
  • VERA N/A
  • Revenue Growth
  • COUR 7.10
  • VERA N/A
  • 52 Week Low
  • COUR $5.76
  • VERA $18.53
  • 52 Week High
  • COUR $13.56
  • VERA $51.61
  • Technical
  • Relative Strength Index (RSI)
  • COUR 49.22
  • VERA 60.75
  • Support Level
  • COUR $9.91
  • VERA $29.58
  • Resistance Level
  • COUR $10.50
  • VERA $31.97
  • Average True Range (ATR)
  • COUR 0.44
  • VERA 1.32
  • MACD
  • COUR -0.01
  • VERA -0.19
  • Stochastic Oscillator
  • COUR 46.52
  • VERA 43.36

About COUR Coursera Inc.

Coursera Inc is an online learning platform that connects learners, educators, and institutions with the goal of providing educational content that is affordable, accessible, and relevant. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The company operates through three reporting segments: Consumer, Enterprise, and Degrees. The majority of revenue is generated from the Consumer segment. The consumer segment targets individual learners seeking to obtain hands-on learning, gain valuable job skills, receive professional-level certifications, and otherwise increase their knowledge to start or advance their careers.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: